Health Related Quality of Life and Response to Combined Anti-Viral Therapy in Chronic Hepatitis C Patients
Heba Abdel Aziz Abdel Monem;
Abstract
Abstract
Back ground: Chronic hepatitis C virus infection is a major cause of chronic liver disease and death throughout the world. In addition to viral factors, several host factors also are implicated in modulating the effectiveness of IFN- therapy for the treatment of HCV infection. Likely, these host factors play an equally important role in modulating the efficacy of IFN- treatment. Therefore, an understanding of how these factors influence IFN- therapy may provide therapeutic targets to improve the efficacy of IFN- treatment several studies have shown an impaired health-related quality of life in patients with CHC compared to general population whereas treatment for this disease often induces similar symptoms as well.
Aim: to estimate the response rate to combined anti-viral therapy and
to determine the role of host factors in affecting response to combined anti-viral therapy such as host factors , viral factors, hepatic histopathology, also to measure the changes in the HRQoL of the patients after the treatment.
Back ground: Chronic hepatitis C virus infection is a major cause of chronic liver disease and death throughout the world. In addition to viral factors, several host factors also are implicated in modulating the effectiveness of IFN- therapy for the treatment of HCV infection. Likely, these host factors play an equally important role in modulating the efficacy of IFN- treatment. Therefore, an understanding of how these factors influence IFN- therapy may provide therapeutic targets to improve the efficacy of IFN- treatment several studies have shown an impaired health-related quality of life in patients with CHC compared to general population whereas treatment for this disease often induces similar symptoms as well.
Aim: to estimate the response rate to combined anti-viral therapy and
to determine the role of host factors in affecting response to combined anti-viral therapy such as host factors , viral factors, hepatic histopathology, also to measure the changes in the HRQoL of the patients after the treatment.
Other data
| Title | Health Related Quality of Life and Response to Combined Anti-Viral Therapy in Chronic Hepatitis C Patients | Other Titles | قياس جودة الحياه الصحيه و معدل الاستجابه للعلاج المزدوج المضاد للفيروسات بين مرضي الالتهاب الكبدى المزمن سي | Authors | Heba Abdel Aziz Abdel Monem | Issue Date | 2019 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.